CiRA, Kyoto University and Astellas Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells ...Middle East

KYOTO, Japan and TOKYO, April 11, 2023 /PRNewswire/ -- The Center for iPS Cell Research and Application, Kyoto University (Director: Dr. Jun Takahashi; "CiRA") and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") entered into the second phase of a joint...

Hence then, the article about cira kyoto university and astellas second phase joint research agreement signed for medical applications of ips cells was published today ( Wednesday 12/04/2023 - 04:16 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CiRA, Kyoto University and Astellas Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells )

Also on site :

• Kristen Stewart Tapped to Play '80s Feminist Icon
• Iranian football players celebrated in Tehran
• Russian oil supplies to India surge – media